1[1]Samama MM,Bara L,Gerotziafas GT.Mechanisms for the antithromortic activity in man of low molecular weight heparins (LMWHs).Haemostasis,1994,24:105
2[2]Melandri G,Semprini F,Cervi V,et al.Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the pr esence of activated platelets in healthy subjects.Am J Cardiol,1993,72:450
3[3]Warkentin TE,Levine MN,Hirsh J,et al. Heparin-induced thrombocytopenia in pa tients treated with low-molecularyweight heparin or unfractionated heparin. N Engl J Med,1995,332:1 330
4[4]Fragmin during lnstability in Coronary Artery Disease(FRISC)Study Group.Low- molecular-weight heparin during instability in coronary artery disease.Lancet ,1996,347:561
5[5]Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin versus r egular heparin or aspirin in the treatment of unstable angina and silent ischemi a.J Am Coll Cardiol,1995,26:313
6[6]Cohen M,Demers C,Gurfinkkel EP,et al.A comparison of low-molecular-weight heparinn with unfractionated heparin for unstable coronary artery disease.N Engl J Med,1997,337:447
